EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Personalized tobramycin dosing in children with cystic fibrosis: an AUC 24 -guided approach

Kiera H Harwood iD, Stephen Duffull, Shivanthan Shanthikumar, Alice Lei, Sarath Ranganathan, Phil Robinson, Indy Sandaradura iD, Tony Lai, Amanda Gwee iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00278-25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Kiera H Harwood und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Tobramycin, Cystic Fibrosis, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tobramycin is commonly used for the treatment of pulmonary exacerbations in children with cystic fibrosis (CF). Currently, a standard dose of 10 mg/kg daily is used in all children. We aim to develop a population pharmacokinetic (popPK) model of tobramycin in children with CF and determine the: (i) effect of cystic fibrosis transmembrane conductance regulator (CFTR) modulators on tobramycin pharmacokinetics (PK); (ii) attainment of the commonly used serum steady state area under the concentration-time curve target (AUC 24,ss ) of 80–110 mg/L⋅h with standard dosing; and (iii) generate an optimized fully individualized dosing strategy to improve target attainment. Multicenter prospective observational study of children with CF aged 0–19 years receiving IV tobramycin who had ≥1 serum concentration measured. A popPK model was developed using nonlinear mixed-effect modeling, and simulations were performed to assess study aims. Overall, 63 children had 450 serum tobramycin concentrations. A one-compartment popPK model, including age, weight, a renal maturation model, and estimated glomerular filtration rate as covariates, was developed. With standard dosing, 1/3 of children achieved the target AUC 24,ss with younger children (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TobramycinCystic FibrosisAnti-Bacterial AgentsHumansChildChild, PreschoolAdolescentMaleFemaleInfantCystic Fibrosis Transmembrane Conductance RegulatorProspective StudiesYoung AdultArea Under CurvePrecision MedicineInfant, NewbornAminophenolsQuinolones

Stichwörter der Autor:innen

aminoglycosidescystic fibrosispopulation pharmacokinetics

Substanzen

TobramycinAnti-Bacterial AgentsCystic Fibrosis Transmembrane Conductance RegulatorivacaftorAminophenolsQuinolones

Autor:innen und Institutionen

  • Department of Paediatrics, The University of Melbourne, , Parkville, Victoria, Australia.
  • Antimicrobials Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Certara, Princeton, New Jersey, USA.
  • Department of Respiratory and Sleep Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Respiratory Diseases Group, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

ORCID-Profile: Kiera H Harwood, Indy Sandaradura, Amanda Gwee

Zitieren

APA

Harwood, K. H., Duffull, S., Shanthikumar, S., Lei, A., Ranganathan, S., Robinson, P., Sandaradura, I., Lai, T., & Gwee, A. (2025). Personalized tobramycin dosing in children with cystic fibrosis: an AUC 24 -guided approach. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00278-25

Vancouver

Harwood KH, Duffull S, Shanthikumar S, Lei A, Ranganathan S, Robinson P, et al. Personalized tobramycin dosing in children with cystic fibrosis: an AUC 24 -guided approach. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00278-25

BibTeX
@article{Harwood2025,
  author = {Harwood, Kiera H and Duffull, Stephen and Shanthikumar, Shivanthan and Lei, Alice and Ranganathan, Sarath and Robinson, Phil and Sandaradura, Indy and Lai, Tony and Gwee, Amanda},
  title = {Personalized tobramycin dosing in children with cystic fibrosis: an AUC 24 -guided approach},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00278-25}
}
Kostenlos starten →